For the first time, researchers at the University of Minnesota Twin Cities showed that non-invasive brain stimulation can change a specific brain mechanism that is directly related to human behavior.
The stress-induced mechanisms that cause our brain to produce feelings of fear in the absence of threats — such as in PTSD — have been mostly a mystery. Now, neurobiologists have identified the changes in brain biochemistry and mapped the neural circuitry that cause generalized fear experiences.
A new population study led by researcher Tomas Paus , professor of psychiatry and neuroscience at the University of Montreal and researcher at CHU Sainte-Justine, highlights the respective roles of maternal and fetal genes in the growth of the baby's cerebral cortex .
“While our research does not prove that veterans who experienced these injuries will develop Alzheimer’s disease, it raises the possibility that they may be on a pathway leading to dementia,” said Dr. Ge Li, the paper's first author and an associate professor of psychiatry and behavioral sciences at UW Medicine.
Space travel and zero gravity can take a toll on the body. A new study has found that astronauts with no prior history of headaches may experience migraine and tension-type headaches during long-haul space flight, which includes more than 10 days in space. The study was published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Chula Medicine has designed an anti-choke mug with calculated angle, amount, and time of water flow from the mug to the patient’s lips hoping to reduce choking that may lead to lung infection, bring peace of mind to caregivers, and make it safer for patients who will have a better quality of life.
Renowned clinical geneticist Bruce Korf, MD, PhD, FACMG, has been named the recipient of the 2024 ACMG Foundation for Genetic and Genomic Medicine's David L. Rimoin Lifetime Achievement Award in Medical Genetics.
Middle-age veterans who experienced concussions due to blasts from explosive devices may have biomarkers in their spinal fluid similar to people who develop Alzheimer’s disease, according to a new study published in the March 13, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The Speech Accessibility Project, which aims to train voice recognition technologies to understand people with diverse speech patterns and disabilities, is recruiting U.S. and Puerto Rican adults with cerebral palsy.
Researchers investigating how exactly the brain processes the incoming stream of information from the heart and lungs, discovered that specific neurons in the thalamus are actively involved in processing cardiac and respiratory signals.
The Portman lab at the Del Monte Institute for Neuroscience at the University of Rochester discovered that the male roundworms use pheromones and touch signals to determine the sex, age, nutritional health, and mating history of the hermaphrodites and show preference toward worms that have not previously mated with another male and are nutritionally healthy.
Sylvester Comprehensive Cancer Center and the North American Neuroendocrine Tumor Society will present a regional educational conference on April 6 focusing on neuroendocrine tumors (NET) and the latest knowledge for optimal NET management.
The Angelman Syndrome Foundation (ASF) and the Foundation for Angelman Syndrome Therapeutics (FAST) are hosting the inaugural Angelman Syndrome (AS) Congressional Advocacy Day in Washington, D.C.
The risk of stroke tied to sleep apnea may vary for Black people and white people, according to a study published in the March 6, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released today, March 6, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
Fragile X syndrome is one of the most commonly inherited forms of autism and intellectual disability, and no treatment currently exists. But a team of University of Illinois researchers has discovered a novel receptor function that may be used in a therapeutic approach to treatment.
People who have headaches after experiencing concussions may also be more likely to have higher levels of iron in areas of the brain, which is a sign of injury to brain cells, according to a preliminary study released today, March 5, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online.
In the mid-1990s, Dr. Edward (Ted) Reynolds, then president of ILAE, recognized that epilepsy required global solutions. His ideas blossomed into the Global Campaign Against Epilepsy and established partnerships between ILAE, the World Health Organization, and the International Bureau for Epilepsy.
New Cleveland Clinic-led research points to sildenafil (Viagra) as a potential treatment for Alzheimer’s disease. The study provides evidence from computational models, insurance claims data and observations from brain cells in Alzheimer’s patients.
Sildenafil is the main component of drugs used to treat erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study released today, March 4, 2024. The study will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study examined four monoclonal antibodies for MS: natalizumab, ocrelizumab, rituximab and ofatumumab.
The International Commission on Non-Ionizing Radiation Protection (ICNIRP) has identified a lack of consensus among public health officials about whether SWL from artificial sources disrupts circadian rhythm, and if so, whether SWL-disrupted circadian rhythm is associated with adverse health outcomes.
A special session at the American Epilepsy Society meeting in December 2023 reviewed progress on the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP) and discussed strategies for moving forward.
Children’s Hospital Los Angeles (CHLA) neurologist Shafali Spurling Jeste, MD, has been named the 2024 recipient of the prestigious Martha Bridge Denckla Award from the Child Neurology Society. This award—named after a physician who pioneered the field of developmental cognitive neurology—honors physician-scientists of international standing who conduct research and clinical care focused on neurodevelopmental and neurobehavioral disorders.
In a new study, published online today in Scientific Reports, researchers found differences in how people with ICD process the consequences of their actions compared to those without ICD, both on and off medication.
People who experience sleep apnea may be more likely to also have memory or thinking problems, according to a preliminary study released today, March 3, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study shows a positive association but did not determine whether sleep apnea causes cognitive decline.
A University of Delaware lab is now pioneering the use of video games – specifically Nintendo Switch's Ring Fit – as an intervention to enhance movement and motor skills for children with autism. The research further demonstrates the positive impact of exercise-based games on cognition and social interactions.
Saint Louis University associate professor of health management and policy in the College for Public Health and Social Justice, SangNam Ahn, Ph.D., recently published a paper in Journal of Clinical Psychology that examines the relationship between childhood adversity, and psychiatric decline as well as adult adversity and psychiatric and cognitive decline.
UCLA Health researchers have discovered a group of specialized support cells in the brain that can regulate behaviors associated with human neuropsychiatric disorders.
Johns Hopkins Medicine neuroscientists say they have found a new function for the SYNGAP1 gene, a DNA sequence that controls memory and learning in mammals, including mice and humans.
Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.
UT Southwestern Medical Center researchers have developed an artificial intelligence (AI) method that writes its own algorithms and may one day operate as an "automated scientis" to extract the meaning behind complex datasets.
Supported by a $2 million R01 grant from the National Institutes of Health, the Auerbach Lab at the Beckman Institute for Advanced Science and Technology will examine how different genes associated with autism spectrum disorders may similarly impact our brain’s neurons, resulting in heightened sensitivity to sounds.
Individuals with Williams syndrome have a gregarious “cocktail party” personality, while those with the opposite genetic alteration, in contrast, tend to have autistic traits and are prone to struggle socially. Research from UC San Diego sheds new light on the gene responsible.
For children and teens, irregular meals such as skipped breakfasts are linked to an increased risk of frequent headaches, according to a new study published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that for those ages 12 to 17, substance use and exposure, specifically electronic cigarettes (e-cigarettes), were associated with frequent headaches.
For people with drug-resistant epilepsy, having a dog companion trained in detecting seizures and other epilepsy-related tasks may reduce the amount of seizures they have, according to new research published in the February 28, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. For the study, researchers looked at adults with severe epilepsy who have been unable to find effective treatment to reduce seizures.
For people with stroke, social factors such as education, neighborhood and employment may be linked to whether they receive treatment with clot-busting drugs, according to a preliminary study released today, February 28, 2024, that will be presented at the American Academy of Neurology’s 76th Annual Meeting taking place April 13–18, 2024, in person in Denver and online. The study looked at people with ischemic stroke, which is caused by a blockage of blood flow to the brain and is the most common type of stroke.
New research at the UNC School of Medicine provides new insights into the brain processes that underlie cocaine addiction. The findings are crucial for developing new therapeutics and identifying an imaging marker for cocaine use disorders.
Mitzi Gonzales, PhD, a board-certified neuropsychologist, has joined Cedars-Sinai as director of Translational Research in the Jona Goldrich Center for Alzheimer’s and Memory Disorders in the Department of Neurology at Cedars-Sinai.
Researchers at Washington University School of Medicine in St. Louis have found that brain cell activity during sleep is responsible for propelling fluid into, through and out of the brain, cleaning it of debris.
Researchers at the Icahn School of Medicine at Mount Sinai and others have harnessed the power of machine learning to identify key predictors of mortality in dementia patients. The study, published in the February 28 online issue of Communications Medicine, addresses critical challenges in dementia care by pinpointing patients at high risk of near-term death and uncovers the factors that drive this risk. Unlike previous studies that focused on diagnosing dementia, this research delves into predicting patient prognosis, shedding light on mortality risks and contributing factors in various kinds of dementia.
Physician scientists at The Ohio State University Wexner Medical Center and College of Medicine are studying why multiple sclerosis (MS) worsens as patients grow older. The "Aging with MS Clinic" provides complete care for older adults with MS.